Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

APPENDIX 3B

3 May 2011 07:00

2 May 2011

We enclose an Appendix 3B detailing the expiration of the following unlisted Oilex Ltd Options:

350,000 options exercisable @ $2.70 expiry date 30 April 2011

For and on behalf of Oilex Ltd

Ben Clube

Finance Director / Company Secretary

cc: Directors - BMc/RB/MC/LLB/RM

Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/ 2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity OILEX LTD ABN 50 078 652 632

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

+Class of +securities issued or to be issued Number of +securities issued or to be issued (if known) or maximum number which may be issued Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state: * the date from which they do * the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment * the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment Issue price or consideration Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) Dates of entering +securities into uncertificated holdings or despatch of certificates Number +Class Number and +class of all 253,274,885 Ordinary Shares +securities quoted on ASX (including the securities in clause 2 if applicable) Number +Class Number and +class of all 900,000 $1.75 Options due 30/06/2011 +securities not quoted on ASX (including the 900,000 $2.25 Options due 30/6/11 securities in clause 2 if applicable) 3,900,000 $2.00 Options due 1/07/2011 3,900,000 $2.50 Options due 01/07/2011 500,000 $1.57 Options due 30/09/2011 300,000 $2.75 Options due 31/3/2012 900,000 $2.75 Options due 30/06/2012 2,000,000 $0.30 Options due 15/09/2012 16,787,500 $0.30 Options due 10/11/2012 4,150,000 $0.30 Options due 01/07/2014 8,787,500 $0.37 Options due 10/11/2014 2006 Performance Rights 15,000 Tranche 1 expire 1/07/2011 2008 Performance Rights 21,000 Tranche 1 expire 1/07/2013 22,000 Tranch 2 expire 1/07/2013 22,000 Tranche 3 expire 1/07/2013 Dividend policy (in the N/A case of a trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation ofsecurities34 Type of securities (tick one) (a) Securities described in Part 1 (b) All other securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

Quotation agreement

1. +Quotation of our additional +securities is in ASX's absolute discretion.

ASX may quote the +securities on any conditions it decides.

11. We warrant the following to ASX.

* The issue of the +securities to be quoted complies with the law and is not

for an illegal purpose.

* There is no reason why those +securities should not be granted +quotation.

* An offer of the +securities for sale within 12 months after their issue

will not require disclosure under section 707(3) or section 1012C(6) of the

Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

* Section 724 or section 1016E of the Corporations Act does not apply to any

applications received by us in relation to any +securities to be quoted and

that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted. * We warrant that if confirmation is required under section 1017F of the

Corporations Act in relation to the +securities to be quoted, it has been

provided at the time that we request that the +securities be quoted.

* If we are a trust, we warrant that no person has the right to return the

+securities to be quoted under section 1019B of the Corporations Act at the

time that we request that the +securities be quoted.

12. We will indemnify ASX to the fullest extent permitted by law in respect of

any claim, action or expense arising from or connected with any breach of

the warranties in this agreement.

13. We give ASX the information and documents required by this form. If any

information or document not available now, will give it to ASX before

+quotation of the +securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and

complete.

Sign here: .............................................. Date: 2 May 2011

(Finance Director / Company Secretary)

Print name: Ben Clube

vendor
Date   Source Headline
24th Aug 20177:00 amRNSCore Analysis and Review Confirms Cambay Potential
7th Aug 20177:00 amRNSExpiry of Unlisted Options
31st Jul 20177:49 amRNSSecurities Trading Policy
31st Jul 20177:00 amRNSQuarterly Report 30 June 2017
19th Jun 20177:00 amRNSPartial Receipt of Outstanding Cash Calls
19th Jun 20177:00 amRNSTrading Halt
6th Jun 20177:10 amRNSCambay PSC Workover and Project Update
30th May 20177:59 amRNSAppendix 3X P Haywood
30th May 20177:47 amRNSOilex Appoints New UK Based Non-Executive Director
23rd May 20177:00 amRNSCambay Production Update - C-73 and C-77
22nd May 20179:31 amRNSTranche 2 Unlisted Options Issued
12th May 201710:10 amRNSBhandut and Cambay Updates
10th May 20179:57 amRNSAppendix 3B Issue of Shares & Section 708 Notice
3rd May 20177:00 amRNSResults of 3 May 2017 General Meeting
28th Apr 20179:31 amRNSQuarterly Report 31 March 2017
28th Apr 20179:20 amRNSMobilisation of Workover Rig at Cambay
21st Apr 20178:19 amRNSChange of ASX Share Registry Address
21st Apr 20177:00 amRNSAward of Key Contracts Cambay-23z Core Analysis
18th Apr 20177:00 amRNSNotice of Change of Substantial Interest
6th Apr 20177:00 amRNSNotice of Change of Substantial Interest
4th Apr 20178:28 amRNSOilex Engagement via Vox Markets
3rd Apr 20177:00 amRNSNotice of General Meeting
31st Mar 20179:16 amRNSAppendix 3B Issue of Shares and Section 708 Notice
31st Mar 20177:00 amRNSOilex Investor Presentation April 2017
24th Mar 20177:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
17th Mar 20177:08 amRNSAppendix 3B
17th Mar 20177:00 amRNSAppendix 3Y J Salomon
17th Mar 20177:00 amRNSManaging Director - Contract Extension
16th Mar 20177:00 amRNSInterim Report 31 December 2016
16th Mar 20177:00 amRNSReinstatement to Official Quotation
15th Mar 201710:09 amRNSPlacement to Fund Cambay Work Programme
15th Mar 20177:00 amRNSSuspension of Trading on ASX
13th Mar 20177:00 amRNSTrading Halt
1st Mar 20177:00 amRNSCancellation of Unlisted Options
23rd Feb 20177:57 amRNSOilex Appoints New Chairman
13th Feb 20177:00 amRNSCancellation of Unlisted Options
30th Jan 20179:18 amRNSQuarterly Report 31 December 2016
30th Jan 20179:09 amRNSOilex Investor Presentation Jan Feb 2017
4th Jan 20177:00 amRNSCancellation of Unlisted Options
19th Dec 20167:00 amRNSAppendix 3B - Issue of Retention Rights
19th Dec 20167:00 amRNSAppendix 3Y J Salomon
13th Dec 20168:23 amRNSOilex tenders for 55% interest in Cambay PSC
6th Dec 20167:00 amRNSExpiry of Unlisted Options
24th Nov 20167:00 amRNSAppendix 3Y J Salomon
24th Nov 20167:00 amRNSAppendix 3B
23rd Nov 20167:00 amRNSResults of Annual General Meeting 23 November 2016
23rd Nov 20167:00 amRNSWaiver of ASX Listing Rule 10.13.5
23rd Nov 20167:00 amRNSChairman's Address to Shareholders
14th Nov 20167:00 amRNSExpiry of Unlisted Options
7th Nov 20167:00 amRNSExpiry of Unlisted Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.